Quest Diagnostics Reports First Quarter 2019 Financial Results

Go back to Quest Diagnostics Reports First Quarter 2019 Financial Results

Quest Diagnostics (DGX) PT Raised to $102 at SunTrust

April 23, 2019 3:50 PM EDT

SunTrust analyst David MacDonald raised the price target on Quest Diagnostics (NYSE: DGX) to $102.00 (from $96.00) while maintaining a Hold rating.

solid execution in a tough environmentlong-term the big guys win... More

Quest Diagnostics (DGX) Tops Q1 EPS by 4c

April 23, 2019 6:46 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.40, $0.04 better than the analyst estimate of $1.36. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.

Outlook for full-year 2019 remains unchanged

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.

... More